Amir M Hossini

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 7

Top Topics

Hidradenitis Suppurativa

Top Venues

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Christos C Zouboulis, Amir M Hossini, Xiaoxiao Hou, Chaoxuan Wang, Karsten-Henrich Weylandt, Anne Pietzner
Effects of Moringa oleifera Seed Oil on Cultured Human Sebocytes In Vitro and Comparison with Other Oil Types. International journal of molecular sciences 24 (12) (2023)
Christos C Zouboulis, Xiaoxiao Hou, Henriette von Waldthausen, Konstantin C Zouboulis, Amir M Hossini
HS 3D-SeboSkin Model Enables the Preclinical Exploration of Therapeutic Candidates for Hidradenitis Suppurativa/Acne Inversa. Pharmaceutics 15 (2) (2023)
Christos C Zouboulis, Amir M Hossini, Xiaoxiao Hou, Chaoxuan Wang, Karsten-Henrich Weylandt, Anne Pietzner
Effects of Moringa oleifera Seed Oil on Cultured Human Sebocytes In Vitro and Comparison with Other Oil Types. International journal of molecular sciences 24 (12) (2023)
Christos C Zouboulis, Amir M Hossini, Xiaoxiao Hou, Chaoxuan Wang, Karsten-Henrich Weylandt, Anne Pietzner
Effects of Moringa oleifera Seed Oil on Cultured Human Sebocytes In Vitro and Comparison with Other Oil Types. International journal of molecular sciences 24 (12) (2023)
Christos C Zouboulis, Xiaoxiao Hou, Henriette von Waldthausen, Konstantin C Zouboulis, Amir M Hossini
HS 3D-SeboSkin Model Enables the Preclinical Exploration of Therapeutic Candidates for Hidradenitis Suppurativa/Acne Inversa. Pharmaceutics 15 (2) (2023)
Christos C Zouboulis, Xiaoxiao Hou, Henriette von Waldthausen, Konstantin C Zouboulis, Amir M Hossini
HS 3D-SeboSkin Model Enables the Preclinical Exploration of Therapeutic Candidates for Hidradenitis Suppurativa/Acne Inversa. Pharmaceutics 15 (2) (2023)
Christos C Zouboulis, Xiaoxiao Hou, Henriette von Waldthausen, Konstantin C Zouboulis, Amir M Hossini
HS 3D-SeboSkin Model Enables the Preclinical Exploration of Therapeutic Candidates for Hidradenitis Suppurativa/Acne Inversa. Pharmaceutics 15 (2) (2023)